Martin Michaelis, PhD profile page

Martin Michaelis is a professor of molecular medicine at the University of Kent, Canterbury, UK, and a research group leader at the Dr. Petra Joh Research Institute in Frankfurt am Main, Germany. His research focuses on the investigation of acquired drug resistance in cancer using the Resistant Cancer Cell Line (RCCL) collection, a unique resource consisting of more than 3,000 drug-adapted cancer cell lines. Additional research interests include the identification of virulence mechanisms and therapeutic targets in viruses, and meta-research on practices in the life sciences, with a focus on reproducibility and ethical standards.
He received his Pharmacy Degree and his PhD from the Goethe-University, Frankfurt am Main, Germany.